BRC
Brady Corporation
BRC offers stronger valuation, but that advantage does not outweigh its weaker overall profile.
CAT
Caterpillar Inc.
CAT has a slight edge over BRC overall, supported by stronger modeled upside and stronger fundamentals.
BRC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Healthy | |
| Strong |
BRC's revenue, profitability, cash flow and balance sheet are all currently healthy.
CAT Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Strong | |
| Strong |
CAT's revenue, profitability, cash flow and balance sheet are all currently healthy.
BRC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 12x | $82.62 | — |
| Cheap | 16x | $68.34 | -17% |
| Fair | 18x | $78.83 | -4.6% |
| Current | 19x | $82.62 | — |
| Expensive | 21x | $92.39 | +12% |
Historical ranges are pointers, not guarantees.
BRC has the edge over CAT in the historical PE scenario, which offers more potential upside but is not a forecast.
CAT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 15x | $380 | -37% |
| Fair | 18x | $461 | -24% |
| Forward | 20x | $605 | — |
| Current | 24x | $605 | — |
| Expensive | 33x | $840 | +39% |
Historical ranges are pointers, not guarantees.
CAT's PE is in its expensive range at 24x. If earnings grow as analysts expect, today's price would be 20x next year's earnings, in its fair range.
BRC Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly weakening | |
| Limited | |
| High |
Analysts expect strong earnings and revenue growth for BRC, but weaker profitability.
CAT Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Growth | |
| Improving | |
| Moderate | |
| Low |
CAT has the edge over BRC on the outlook, with more favorable profitability expectations.
BRC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $6.75 | +57% |
| Q3 2026 | $4.30 | +9.1% |
| Q2 2026 | $4.40 | +8.9% |
| Q1 2026 | $4.28 | +7% |
| Q4 2025 | $4.10 | +0.7% |
| Q3 2025 | $3.94 | -3.2% |
| Q2 2025 | $4.04 | +3.1% |
| Q1 2025 | $4.00 | +4.4% |
| Q4 2024 | $4.07 | +10% |
BRC has the edge over CAT on earnings, with more consistent year-over-year improvement.
CAT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $29.73 | +17% |
| Q3 2026 | $25.48 | +31% |
| Q2 2026 | $23.23 | +18% |
| Q1 2026 | $20.08 | -2% |
| Q4 2025 | $18.81 | -15% |
| Q3 2025 | $19.46 | -9.7% |
| Q2 2025 | $19.64 | -10% |
| Q1 2025 | $20.50 | -7.4% |
| Q4 2024 | $22.05 | +9.6% |
CAT earned $25.48 per share over the past year, up 31% from the year before.
BRC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $436.9M | +10% |
| Q2 2026 | $435.2M | +14% |
| Q1 2026 | $384.1M | +7.7% |
| Q4 2025 | $405.3M | +7.5% |
| Q3 2025 | $397.3M | +16% |
| Q2 2025 | $382.6M | +11% |
| Q1 2025 | $356.7M | +11% |
| Q4 2024 | $377.1M | +14% |
BRC's revenue has grown year over year for eight quarters in a row: $437M last quarter, up 10% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 14% | -1.2 points |
| Q2 2026 | 17% | -0.7 points |
| Q1 2026 | 16% | +1.8 points |
| Q4 2025 | 17% | +1.1 points |
| Q3 2025 | 15% | -4.4 points |
| Q2 2025 | 18% | -0.9 points |
| Q1 2025 | 14% | -2.4 points |
| Q4 2024 | 16% | -2.4 points |
BRC's operating margin was 14% last quarter, down 1.2 points from the same quarter a year ago.
CAT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $20.7B | +17% |
| Q2 2026 | $20.5B | +24% |
| Q1 2026 | $17.4B | +22% |
| Q4 2025 | $19.1B | +18% |
| Q3 2025 | $17.6B | +9.5% |
| Q2 2025 | $16.6B | -0.7% |
| Q1 2025 | $14.2B | -9.8% |
| Q4 2024 | $16.2B | -5% |
CAT's revenue has grown year over year for five quarters in a row: $20.7B last quarter, up 17% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | +3.1 points |
| Q2 2026 | 21% | +3.6 points |
| Q1 2026 | 18% | -0.4 points |
| Q4 2025 | 14% | -4.1 points |
| Q3 2025 | 17% | -2.2 points |
| Q2 2025 | 17% | -3.6 points |
| Q1 2025 | 18% | -4.2 points |
| Q4 2024 | 18% | -0.3 points |
CAT has the edge over BRC on profitability, with a higher operating margin.
BRC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $60.7M | +23% |
| Q2 2026 | $67.2M | +21% |
| Q1 2026 | $42.3M | +30% |
| Q4 2025 | $22.4M | +39% |
| Q3 2025 | $49.4M | -33% |
| Q2 2025 | $55.6M | -14% |
| Q1 2025 | $32.5M | +$45.9M |
| Q4 2024 | $16.1M | -68% |
BRC has the edge over CAT on cash flow, with more consistent year-over-year improvement.
CAT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $3.7B | +19% |
| Q2 2026 | $3.8B | +47% |
| Q1 2026 | $1.1B | +97% |
| Q4 2025 | $2.7B | +0.1% |
| Q3 2025 | $3.1B | -1.5% |
| Q2 2025 | $2.6B | -4.2% |
| Q1 2025 | $579M | -63% |
| Q4 2024 | $2.7B | -22% |
CAT generated $11.3B in free cash flow over the past year, up 26% from the year before.
BRC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.1% | -64K shares |
| 1 year | -0.7% | -342K shares |
| 3 years | -4.2% | -2.1M shares |
| 5 years | -8.9% | -4.7M shares |
| Available history | -11% | -6M shares |
BRC has 48M diluted shares, down 0.7% from a year ago, with $42M in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $28.1M |
| Q2 2026 | $5.2M |
| Q1 2026 | $4.9M |
| Q4 2025 | $4.1M |
| Q3 2025 | $17.7M |
| Q2 2025 | $33.2M |
| Q1 2025 | — |
| Q4 2024 | — |
BRC spent $42M buying back its own shares over the past year, down 17% from the year before.
CAT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.3% | -1.6M shares |
| 1 year | -2.1% | -9.9M shares |
| 3 years | -10% | -51.7M shares |
| 5 years | -16% | -86.7M shares |
| Available history | -19% | -107M shares |
CAT has the edge over BRC on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.2B |
| Q2 2026 | $1.5B |
| Q1 2026 | $5B |
| Q4 2025 | $340M |
| Q3 2025 | $362M |
| Q2 2025 | $828M |
| Q1 2025 | $3.7B |
| Q4 2024 | $640M |
CAT spent $8.1B buying back its own shares over the past year, up 47% from the year before.
BRC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.6x | Net Cash |
| Q2 2026 | -0.5x | Net Cash |
| Q1 2026 | -0.3x | Net Cash |
| Q4 2025 | -0.2x | Net Cash |
| Q3 2025 | -0.3x | Net Cash |
| Q2 2025 | -0.5x | Net Cash |
| Q1 2025 | -0.5x | Net Cash |
| Q4 2024 | -0.5x | Net Cash |
BRC has the edge over CAT on leverage, with a lower net debt burden relative to earnings.
CAT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.5x | Net Cash |
| Q2 2026 | -0.4x | Net Cash |
| Q1 2026 | -0.3x | Net Cash |
| Q4 2025 | 2.0x | Healthy |
| Q3 2025 | -0.6x | Net Cash |
| Q2 2025 | -0.4x | Net Cash |
| Q1 2025 | -0.3x | Net Cash |
| Q4 2024 | 1.6x | Healthy |
CAT has more cash than debt.
BRC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 45.6 | Neutral |
| Stochastic | 11.6 | Oversold |
BRC's weekly RSI is 46 (neutral) and its Stochastic is 12 (oversold).
CAT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.7 | Neutral |
| Stochastic | 6.7 | Oversold |
CAT's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
BRC PE vs Industrials Sector
| Metric | BRC | Sector median | Relative |
|---|---|---|---|
| PE | 19x | 24x | 20% below |
| PE % | 60 | 58 | 2 pts above |
BRC has the edge over CAT on valuation relative to its sector.
CAT PE vs Industrials Sector
| Metric | CAT | Sector median | Relative |
|---|---|---|---|
| PE | 24x | 24x | 1.1% below |
| PE % | 69 | 58 | 11 pts above |
CAT is trading at 24x earnings, in line with the Industrials sector's median of 24x.
BRC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $82.7 | 0.1% below |
| 20 week MA | $88.2 | 6.3% below |
| 50 week MA | $85.7 | 3.6% below |
| 100 week MA | $79.3 | 4.3% above |
| 200 week MA | $69.5 | 19% above |
BRC has pulled back, but its long-term trend is still up: it's below its 8-, 20- and 50-week averages, but 19% above its 200-week average.
CAT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $709.0 | 15% below |
| 20 week MA | $797.0 | 24% below |
| 50 week MA | $771.3 | 22% below |
| 100 week MA | $586.7 | 3.2% above |
| 200 week MA | $443.1 | 37% above |
CAT has pulled back, but its long-term trend is still up: it's below its 8-, 20- and 50-week averages, but 37% above its 200-week average.
BRC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $57.5 | $49.7 | -14% |
| 2021 | $49.7 | $53.8 | +8.2% |
| 2022 | $53.8 | $46.5 | -14% |
| 2023 | $46.5 | $58.7 | +26% |
| 2024 | $58.7 | $73.9 | +26% |
| 2025 | $73.9 | $80.1 | +8.3% |
| 2026 YTD | $80.1 | $82.6 | +3.2% |
BRC has finished higher in four of the last six years. It's up 3.2% so far in 2026.
CAT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $148.3 | $179.6 | +21% |
| 2021 | $179.6 | $206.2 | +15% |
| 2022 | $206.2 | $239.9 | +16% |
| 2023 | $239.9 | $295.7 | +23% |
| 2024 | $295.7 | $364.9 | +23% |
| 2025 | $364.9 | $583.0 | +60% |
| 2026 YTD | $583.0 | $605.3 | +3.8% |
CAT has the edge over BRC on returns for 2026, with the stronger performance.